Lixisenatide is a synthetic peptide active pharmaceutical ingredient classified as a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is a 44-amino-acid peptide designed to interact with GLP-1 receptors and regulate glucose-dependent metabolic pathways.
Lixisenatide acts through activation of the GLP-1 receptor. Its pharmacological activity is associated with increased glucose-dependent insulin release, decreased glucagon secretion, and slowing of gastric emptying.
Lixisenatide is associated with regulated pharmaceutical formulations and research programs related to type 2 diabetes mellitus and glucose control. It is used in peptide pharmaceutical development, formulation research, analytical studies, and specialized metabolic drug development programs.
Lixisenatide API requires stringent control of peptide identity, assay, purity, related peptides, high molecular weight impurities, water content, residual solvents, biological activity, bacterial endotoxins, and other critical quality parameters.
Validated peptide analytical methods, including high-performance liquid chromatography, mass spectrometry, and peptide mapping, may be used to evaluate the identity and quality of Lixisenatide API.
Swapnroop Drugs and Pharmaceuticals supports Lixisenatide API sourcing and specialized pharmaceutical raw material requirements for pharmaceutical companies, peptide formulation developers, research organizations, laboratories, and international buyers. Product specifications and documentation are supplied according to applicable customer and project requirements.
Lixisenatide API is associated with:
Available documentation may include, subject to product and supply requirements:
Certificate of Analysis – COA
Material Safety Data Sheet – MSDS / SDS
Product Specification Sheet
Analytical Test Report
HPLC Purity Data, where available
Peptide Mapping Data, where available
Mass Spectrometry Data, where available
Related Peptide Information
Bacterial Endotoxin Test Information
Storage and Handling Information
Stability Information, where available
Regulatory and technical documentation, subject to agreement
Swapnroop Drugs and Pharmaceuticals is a pharmaceutical raw material supplier based in Maharashtra, India, serving pharmaceutical, peptide, research, and development requirements.
We focus on:
Swapnroop Drugs and Pharmaceuticals supplies and supports Lixisenatide API requirements for pharmaceutical companies, peptide formulation developers, metabolic drug research organizations, laboratories, and international buyers.
For Lixisenatide API requirements, customers may contact our team for product availability, specifications, documentation, quantity, packaging, storage conditions, and commercial information.
Company Name: Swapnroop Drugs and Pharmaceuticals
Location: Maharashtra, India
Email: enquiry@sdp.org.in
Website: www.sdp.org.in